NCT05165719 Validation of 'Corona-T-test' for Assessment of SARS-COV-2-specific T-cell Response After COVID-19 or Vaccination Status COMPLETED Phase N/A
NCT05163652 Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) Based on Different COVID-19 Inactivated Vaccine in Adults Aged 18 Years and Above Status UNKNOWN Phase PHASE3
NCT05160779 Impact of Genetic Polymorphisms of Vasoactive Peptides on the Prognosis of Patients With COVID19 Status UNKNOWN Phase NA
NCT05143320 Cognitive, Emotional and Behavioural Impairments in Patients After Sars-Cov2 Infection Status COMPLETED Phase N/A
NCT05142306 A COVID-19 Study to Evaluate Safety and PK of COVID-HIG Administered Through IM, SC, or IV Routes to SARS-CoV-2 Uninfected Adults Status COMPLETED Phase PHASE1
NCT05141058 T Cell Therapy Opposing Novel COVID-19 Infection in Immunocompromised Patients Status RECRUITING Phase PHASE1
NCT05124509 Immune Response to Third Dose of COVID-19 Vaccine in Solid Organ Transplant Status COMPLETED Phase N/A
NCT05119738 Immune Response to Third Dose of SARS-CoV-2 Vaccine in a Cohort of Cancer Patients on Active Treatment Status UNKNOWN Phase N/A
NCT05119348 Transmission of Coronavirus Disease 2019 (COVID19) in Crowded Environments Status COMPLETED Phase NA
NCT05113862 A Phase-I Study of a Nanoparticle-based Peptide Vaccine Against SARS-CoV-2 Status COMPLETED Phase PHASE1
NCT05112848 A Study to Evaluate Safety and Immunogenicity of a COVID-19 Vaccine in People Living With HIV at Risk for SARS-CoV-2 (COVID-19) Status COMPLETED Phase PHASE2
NCT05110911 Does Repeat Influenza Vaccination Constrain Influenza Immune Responses and Protection Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05109611 Nitric Oxide Nasal Spray (NONS) as Prevention for Treatment of Individuals at Risk of Exposure to COVID-19 Infection Status TERMINATED Phase PHASE3
NCT05109559 Ad26.COV2.S as a Heterologous Booster in Adults After Single- or Two-Dose of Inactivated COVID-19 Vaccine Status UNKNOWN Phase PHASE1/PHASE2